FEVGRESLI
Live / Allowed — Publication / registration review complete (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 29 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99623446
- Mark type
- Stylized text
- Filed
- 29 Jan 2026
- Published for opposition
- 14 Apr 2026
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
Prosecution history
- 18 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Mar 2026 — ASSIGNED TO EXAMINER
- 29 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 29 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 29 Jan 2026 — NEW APPLICATION ENTERED